Months after 23andMe CEO Anne Wojcicki publicly stated she wants to take the company she co-founded private, all of the company’s independent board directors have resigned. The board letter to Wojcicki stated that its members preferred resigning over continuing to have a difference of view over the direction of the company. The post Mass Board…
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they’re vital for treating obesity. The post As Insurers Drop GLP-1 Coverage, Advocates Search for a Hero in Obesity appeared first on MedCity News.
Testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.” The post The Truth About Testosterone in Women: What Medicine Has Overlooked appeared first on MedCity News.
Most healthcare organizations are experimenting with AI. Few are preparing to manage AI agents as participants in everyday healthcare workflows. The post Healthcare Is Deploying AI Tools — It’s Not Ready for AI Colleagues appeared first on MedCity News.
By DAVID INTROCASO After having worked in DC for sixteen years, in 2013 I created The Healthcare Policy Podcast. The title was in part intended to be sarcastic because healthcare policymaking in DC is very narrowly drawn. Consequently, healthcare delivery is excessively commodified, reductionistic and financialized or in sum anachronistic and ironically lacking purchase. If the…
KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025. The post KFF: Insurer Participation in ACA Marketplaces Is Down appeared first on MedCity News.
This proposal reflects a broader shift toward more restrictive oversight of inpatient utilization. As CMS finalizes this policy, providers should be aware of the immediate compliance and reimbursement risks associated with the phase-out. The post The IPO List is on the Chopping Block (Again) — What Providers Need to Know appeared first on MedCity News.
Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.85 billion. The deal puts J&J in the mix of pharmaceutical companies developing next-generation cell therapies for applications in autoimmune diseases. The post J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy appeared first on MedCity News.
When employees feel supported in every aspect of their lives, they bring their full potential to work — creating value that resonates throughout the organization. Here are four ways culture-driven benefits deliver meaningful returns, The post Culture-Driven Benefits: The Smartest Investment for Retention and Productivity appeared first on MedCity News.
Brad Kittredge is CEO of Brightside Health, which he co-founded with CMO Mimi Winsberg. They are a large online mental health group that aims a providing more access with higher quality. They have built their own technology stack and medical group, and are in network for about 135m lives. They also take patients from the…